Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
20,679,958
-
Total 13F shares
-
252,002
-
Share change
-
+28,996
-
Total reported value
-
$909,576
-
Price per share
-
$3.61
-
Number of holders
-
20
-
Value change
-
+$57,104
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) as of Q1 2024
As of 31 Mar 2024,
CASI Pharmaceuticals, Inc. - Ordinary Shares, par value US$0.0001 per share (CASI) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
252,002 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, HOWLAND CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, Catalyst Funds Management Pty Ltd, MORGAN STANLEY, SIMPLEX TRADING, LLC, and FMR LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.